How is substance use linked to psychosis? a study of the course and patterns of substance dependence in psychosis

Substance Abuse

Volumn 31, Issue 1, 2010, Pages 58-67

  Saddichha, Sahoo ^a   Sur, Shravani ^b   Sinha, Baxi Neeraj Prasad ^c   Khess, Christoday Raja Jayant ^d  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

^b Ranchi Institute of Neuropsychiatry and Allied Sciences   (India)

^c UNIVERSITY HOSPITAL OF NORTH TEES   (United Kingdom)

^d CENTRAL INSTITUTE OF PSYCHIATRY   (India)

Author keywords

Alcohol; Cannabis; Chronology; Course; Dependence; Psychosis; Substance use

Indexed keywords

ADDICTION; ADULT; ARTICLE; BIPOLAR DISORDER; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; ONSET AGE; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA;

ADULT; AGE OF ONSET; BEHAVIOR, ADDICTIVE; BIPOLAR DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); DISEASE PROGRESSION; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; SUBSTANCE-RELATED DISORDERS;

EID: 77951125087     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897070903442699     Document Type: Article

References (63)

1. Wolfe LH, Sorenson JL. Dual diagnosis patients in the urban psychiatric emergency room. J Psychoactive Drugs. 1989;21:169-175.
2. Kavanagh DJ, McGrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 2002;62:743-755.
3. MueserKT,Yarnold PR, Bellack AS.Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand. 1992;85:48-55.
4. Blanchard JJ, Brown SA, HoranWP, Sherwood AR. Substance use disorders in schizophrenia: review, integration and a proposed model. Clin Psychol Rev. 2000;20:207-234.
5. Cantor-Graee E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Res. 2001;48:69-82.
6. Weaver T, Madden P, Charles V, Stimson G, Renton A, Tyrer P, Barnes T, Bench C, Middleton H, Wright N, Paterson S, Shanahan W, Seivewright N, Ford C; Comorbidity of Substance Misuse and Mental Illness Collaborative study team. Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. Br J Psychiatry. 2003;183:304-313.
7. Strakowski SM, Keck PE Jr, McElroy SL,West SA, Sax KW, Hawkins JM, Kmetz GF, Upadhyaya VH, Tugrul KC, Bourne ML. Twelve-month outcome after a first hospitalization for affective psychosis. Arch Gen Psychiatry. 1998;55:49-55.
8. Drake RE, Wallach MA. Substance abuse among the chronic mentally ill. Hospital Community Psychiatry. 1989;40:1041-1045.
9. Pristach CA, Smith CM.Medication compliance and substance abuse among schizophrenic patients. Hospital Community Psychiatry. 1990;41:1345-1348.
10. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3:181-188.
11. Zisook S, Heaton R, Moranvill, J, Kuck J, Jernigan T, Braff, D. Past substance abuse and clinical course of schizophrenia. Am J Psychiatry. 1992;149:552-553.
12. Rich CL, Motooka MS, Fowler RC, Young, D. Suicide by psychotics. Biol Psychiatry. 1988;23:595-601.
13. Test MA, Wallisch LS, Allness DJ, Ripp K. Substance use in young adults with schizophrenic disorders. Schizophrenia Bull. 1989;15:465-476.
14. Swanson JW, Holzer CE, Ganju VK, Jono, RT. Violence and psychiatric disorder in the community: evidence from the Epidemiologic Catchment Area surveys. Hospital Community Psychiatry. 1990;41:761-770.
15. Belcher JR. On becoming homeless: a study of chronically mentally ill persons. J Community Psychol. 1989;17:173-185.
16. Seeman MV, Lang M, Rector N. Chronic schizophrenia: a risk factor for HIV? Can J Psychiatry. 1990; 35:765-768.
17. Hanson M, Kramer TH, Gross W, Quintana J, Li PW, Asher R. AIDS awareness and risk behaviours among dually disordered adults. AIDS Educ Prevent. 1992;4:41-51.
18. Boyd JH, Burke JD Jr, Gruenberg E, Holzer CE 3rd, Rae DS, George LK, Karno M, Stoltzman R, McEvoy L, Nestadt G. Exclusion criteria of DSM III: a study of co-occurrence of hierarchy-free symptoms. Arch Gen Psychiatry. 1984;41:982-987.
19. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Co-morbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiological Catchment Area (ECA) study. JAMA. 1990;264:2511-2518.
20. Condren RM, O'Connor J, Browne R. Prevalence and patterns of substancemisuse in schizophrenia. A catchment area case-control study. PsychiatricBull. 2001;25:17-20.
21. Hambrecht M, Hafner H. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perpective. Aust N Z J Psychiatry. 2000;34:468-475.
22. Menezes PR, Johnson S, Thornicroft G, Marshall J, Prosser D, Bebbington P, Kuipers E. Drug and alcohol problems among individuals with severe mental illness in South London. Br J Psychiatry. 1996;168:612-619.
23. Soyka M, Albus M, Kathmann N, Finelli A, Hofstetter S, Holzbach R, Immler B, Sand P. Prevalence of alcohol and drug abuse in schizophrenic in patients. Eur Arch Psych Clin Neurosci. 1993;242:362-372.
24. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259-1264.
25. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophrenia Bull. 1998;24:443-455.
26. Mueser KT, Yarnold PR, Levinson DF, Singh H, Bellack AS,Kee K, Morrison RL,Yadalam KG. Prevalence of substance abuse in schizophrenia: demographic and clinical correlates. Schizophr Bull. 1990;16:31-56.
27. Mueser KT, Yarnold PR, Rosenberg SD, Swett C Jr, Miles KM, Hill D. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull. 2000;26(1):179-192.
28. Mueser K, Bellack AS, Blanchard JJ. Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol. 1992;60:845-856.
29. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand. 2007;115:304-309.
30. Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, McGorry PD. Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Aust N Z J Psychiatry. 2005;39:892-898.
31. Goswami S, Singh G, Mattoo SK, Basu D. Courses of substance use and schizophrenia in the dualdiagnosis patients: Is there a relationship? Ind J Med Sci. 2003;57:338-346.
32. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962;10:799-812.
33. FolsteinMF, Folstein SE, McHugh PR.Mini-Mental State-a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
34. Fagerstrom KO, Heatherton T, Kozlowski LT. Nicotine addiction and its assessment. Ear Nose Throat J. 1991;69:763-765.
35. Van Gulick-Bailer M, Maurer K, Hafner H, eds. Schedules for Clinical Assessment in Neuropsychiatry: SCAN, PSE 10 Interview. Bern,Gottingen, Toronto, Seattle: Hans Huber; 1995.
36. World Health Organization (WHO). ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research. (DCR). Geneva: World Health Organization. Geneva; 1993.
37. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J,Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59-20S:22-33.
38. Carlat DJ. Asking questions III: tricks for improving patient recall. In: The Psychiatric Interview: A Practical Guide, 2nd ed. Philadelphia: Lippincott Wlliams & Wilkins, 2005:27-29.
39. Marwaha S, Johnson S. Schizophrenia and employment-a review. Soc Psychiatry Psychiatr Epidemiol. 2004;39:337-349.
40. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Morgan V, Korten A. National Survey of Mental Health and Wellbeing. Report 4. People Living with Psychotic Illness: An Australian Study. Canberra: Mental Health Branch. Commonwealth Department of Health and Aged Care; 1999.
41. Duke PJ, Pantelis C, McPhillips MA, Barnes TR. Co-morbid non-alcohol substance misuse among people with schizophrenia. Epidemiological study in central London. Br J Psychiatry. 2001;179:509-513.
42. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313-321.
43. Sevy S, Robinson DG, Solloway S, Alvir JM, Woerner MG, Bilder R, Goldman R, Lieberman J, Kane J. Correlates of substance abuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psichiatr Scand. 2001;104:367-374.
44. Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry. 2006;188:237-242.
45. Toner BB, Shugar G, Campbell B, DiGasbarro I. Pattern of substance abuse in psychiatric inpatients. Can J Psychiatry. 1991;36:381-383.
46. Kaiser R, Löhrer F, Morgan V, Hambrecht M. Changes in the pattern of substance abuse after the onset of psychosis. Aust N Z J Psychiatry. 2005;39:467-472.
47. Gardner EL, Lowinson JH. Marijuana's interaction with brain reward systems: update 1991. Pharmacol Biochem Behav. 1991;40:571-580.
48. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent onset schizophrenic disorders. Arch Gen Psychiatry. 1994;51:273-279.
49. Degenhardt L, Hall WD. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey ofMental Health and Well-Being. Psychol Med. 2001;31:659-668.
50. Copeland J, Swift W, Rees V. Clinical profile of participants in a brief intervention program for cannabis use disorder. J Subst Abuse Treat. 2001;20:45-52.
51. Tims FM, Dennis ML, Hamilton N, Buchan BJ, Diamond G, Funk R, Brantley LB. Characteristics and problems of 600 adolescent cannabis abusers in outpatient treatment. Addiction. 2002;97:46-57.
52. Park K. Mental Health. In: Park's Textbook of Preventive and Social Medicine. 18th ed. Jabalpur, India: Banarsidas Bhanot Publishers; 2005:632-637.
53. Maldonado R. Study of cannabinoid dependence in animals. Pharmacol Ther. 2002;95:153-164
54. Hall WD, Pacula RL. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge: Cambridge University Press; 2003:298.
55. Leweke FM, Gerth CW, Klosterkotter J. Cannabisassociated psychosis. Current status of research. CNS Drugs. 2004;18:895-910.
56. Iversen L. Cannabis and the brain. Brain. 2003;126:1252-1270.
57. HerkenhamM. Cannabinoid receptor localization in brain: relationship to motor and reward systems. Ann N Y Acad Sci. 1992; 654: 19-32.
58. Hernandez ML, Garcia-Gil L, Berrendro F, Ramos JA, Ferńandez-Ruiz JJ. δ-9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons. J Mol Neurosci. 1997;8:83-91.
59. Leweke FM, Giuffrida A, Wurster U, Emrich HM, Piomelli D. Elevated endogenous cannabinoids in schizophrenia. Neuroreport. 1999;10:1665-1669.
60. Zammit S, Lewis G. Exploring the relationship between cannabis use and psychosis. Addiction. 2004;99:1353-1355.
61. Smit F, Bolier L, Cuijpers P. Cannabis use and the risk of later schizophrenia: a review. Addiction. 2004;99:425-430.
62. Veen ND, Selten J-P, Van Der Tweel I, Feller WG, Hoek HW, Kahn RS. Cannabis use and age at onset of schizophrenia. Am J Psychiatry. 2004;161: 501-506.
63. Ferdinand RF, Sondeijker F, Van Der Ende J, Selten JP, Huizink A, Verhulst FC. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction. 2005;100:612-618.